Venus Remedies Limited has informed the Exchange regarding a press release dated April 25, 2023, titled " Venus Remedies secures Marketing Authorisation from UK MHRA for Cisplatin.".
Venus Remedies Limited has informed the Exchange regarding a press release dated April 25, 2023, titled " Venus Remedies secures Marketing Authorisation from UK MHRA for Cisplatin.".